<?xml version="1.0" encoding="UTF-8"?>
<ref id="B169-biomedicines-08-00060">
 <label>169.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Abdullahi</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>JÃ¤kel</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Behrend</surname>
    <given-names>S.J.</given-names>
   </name>
   <name>
    <surname>Steiger</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Topping</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Krabbe</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Colombo</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Sandig</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Schiergens</surname>
    <given-names>T.S.</given-names>
   </name>
   <name>
    <surname>Thasler</surname>
    <given-names>W.E.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A novel chimeric oncolytic virus vector for improved safety and efficacy as a platform for the treatment of hepatocellular carcinoma</article-title>
  <source>J. Virol.</source>
  <year>2018</year>
  <volume>92</volume>
  <pub-id pub-id-type="doi">10.1128/JVI.01386-18</pub-id>
  <?supplied-pmid 30232179?>
  <pub-id pub-id-type="pmid">30232179</pub-id>
 </element-citation>
</ref>
